CD83 and autoimmune disease: Another group showed that a mouse anti-human CD83 mAb could deplete DC and restrain self-reactive T cell generation in a xenograft temporal-artery plus PBMC SCID mouse model of autoimmune vasculitis indicative of potential utility for anti-CD83 treatment in autoimmune diseases (23).